ORMP
ORAMED PHARMACEUTICALS INC.
ORAMED PHARMACEUTICALS INC. (ORMP) has 14 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.
Insiders have net sold $942K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Nadav Kidron
- Employees:13
- HQ:New York City, NY, US
- IPO:2007-05-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$942K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$176.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Hexter JoshuaFirst filing | COO & CBO | Sale | 137,000 | $611K | Jul 2 | SEC ↗ |
Gabay AvrahamFirst filing | Chief Financial Officer | Sale | 73,360 | $331K | Jul 2 | SEC ↗ |
Related companies
ORAMED PHARMACEUTICALS INC. is in the Healthcare sector.